Subscribe To
Genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that gantenerumab, ...
October 8, 2021, 4:48 pm
Roche's alzheimer's candidate secures fda breakthrough designation
Roche Holdings AG's (OTC: RHHBY) gantenerumab antibody received breakthrough therapy designation from...
October 8, 2021, 3:37 pm
Roche's alzheimer's candidate secures fda breakthrough designation
Roche Holdings AG's (OTC: RHHBY) gantenerumab antibody received breakthrough therapy designation from...
October 8, 2021, 3:37 pm
Roche's alzheimer's candidate secures fda breakthrough designation
Roche Holdings AG's (OTC: RHHBY) gantenerumab antibody received breakthrough therapy designation from...
October 8, 2021, 3:37 pm
Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that gantenerumab, ...
October 8, 2021, 11:40 am
Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that gantenerumab, ...
October 8, 2021, 11:40 am
Ad hoc announcement pursuant to art. 53 lr: genentech's anti-amyloid beta antibody gantenerumab granted fda breakthrough therapy designation in alzheimer's disease
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that gantenerumab, ...
October 8, 2021, 11:40 am
Why did chemocentryx shares soar 70% on friday premarket?
The FDA has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil cytoplasmic autoantibody-a...
October 8, 2021, 8:02 am
Why did chemocentryx shares soar 70% on friday premarket?
The FDA has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil cytoplasmic autoantibody-a...
October 8, 2021, 8:02 am
Why did chemocentryx shares soar 70% on friday premarket?
The FDA has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil cytoplasmic autoantibody-a...
October 8, 2021, 8:02 am
Talem therapeutics announces multi-target antibody discovery research collaboration with pierre fabre
VICTORIA, British Columbia & CASTRES, France--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (...
October 7, 2021, 8:38 am
Talem therapeutics announces multi-target antibody discovery research collaboration with pierre fabre
VICTORIA, British Columbia & CASTRES, France--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (...
October 7, 2021, 8:38 am
Talem therapeutics announces multi-target antibody discovery research collaboration with pierre fabre
VICTORIA, British Columbia & CASTRES, France--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (...
October 7, 2021, 8:38 am
Astrazeneca seeks eua from fda for long-acting antibody, nih director francis collins to step down
Yahoo Finance's Anjalee Khemlani reports on Astrazeneca seeking emergency use approval from the FDA for its long-acting antibody. Johnson & Johnson is...
October 5, 2021, 6:49 pm
Astrazeneca seeks eua from fda for long-acting antibody, nih director francis collins to step down
Yahoo Finance's Anjalee Khemlani reports on Astrazeneca seeking emergency use approval from the FDA for its long-acting antibody. Johnson & Johnson is...
October 5, 2021, 6:49 pm
Astrazeneca seeks eua from fda for long-acting antibody, nih director francis collins to step down
Yahoo Finance's Anjalee Khemlani reports on Astrazeneca seeking emergency use approval from the FDA for its long-acting antibody. Johnson & Johnson is...
October 5, 2021, 6:49 pm
Astrazeneca seeks eua from fda for long-acting antibody, nih director francis collins to step down
Yahoo Finance's Anjalee Khemlani reports on Astrazeneca seeking emergency use approval from the FDA for its long-acting antibody. Johnson & Johnson is...
October 5, 2021, 6:49 pm
Astrazeneca seeks eua from fda for long-acting antibody, nih director francis collins to step down
Yahoo Finance's Anjalee Khemlani reports on Astrazeneca seeking emergency use approval from the FDA for its long-acting antibody. Johnson & Johnson is...
October 5, 2021, 6:49 pm
Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us
AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination...
October 5, 2021, 4:31 am
Astrazeneca seeks emergency use authorisation for covid-19 antibody drug in us
AstraZeneca PLC has requested authorisation in the US for emergency use of its new antibody combination...
October 5, 2021, 4:31 am